Ivizia Dry Eye
NDC Package 82095-700-05
Package Information
Ivizia Dry Eye is wash hands well before use.Instill 1 or 2 drops in the affected eye(s) as needed. Marketed by Laboratoires Thea, this product is identified by NDC 82095-700 and is authorized under FDA application part349.
Identification & Billing
- RxCUI: 2570860 - povidone 0.5 % Ophthalmic Solution
- RxCUI: 2570860 - povidone 5 MG/ML Ophthalmic Solution
- RxCUI: 2586186 - iVIZIA 0.5 % Ophthalmic Solution
- RxCUI: 2586186 - povidone 5 MG/ML Ophthalmic Solution [iVizia]
- RxCUI: 2586186 - iVizia 0.5 % Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 82095 - Laboratoires Thea
- 82095-700 - Ivizia Dry Eye
- 82095-700-05 - 5 mL in 1 BOTTLE, DROPPER
- 82095-700 - Ivizia Dry Eye
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (82095-700). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82095-700-05 identifies a specific commercial package of 5 ml in 1 bottle, dropper of Ivizia Dry Eye, labeled by Laboratoires Thea. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Laboratoires Thea on November 29, 2021. The current certification is valid through December 31, 2022.
How is this Laboratoires Thea product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82095070005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.